Showing 771-780 of 1097 results for "".
- Cutera Introduces Secret DUOhttps://modernaesthetics.com/news/cutera-introduces-secret-duo/2473490/Cutera, Inc. is launching Secret DUO, a skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. Secret DUO is equipped
- Delnova Demonstrates Proof of Concept for ReViVoxhttps://modernaesthetics.com/news/delnova-demonstrates-proof-of-concept-for-revivox/2473478/Delnova’s ReViVox showed reversal or muscle paralysis or weakness in a small cohort of healthy subjects. ReViVox is being developed to resolve side effects that may result from botulinum neurotoxin treatments. In the proof-of-concept study, volunteer subj
- Meet the Beauty Health Company’s New CFO: Michael Monahanhttps://modernaesthetics.com/news/meet-the-beauty-health-companys-new-ceo-michael-monahan/2473471/Michael Monahan is The Beauty Health Company’s new Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition. "Michael
- Evolus Unveils New Branding for Jeuveauhttps://modernaesthetics.com/news/evolus-unveils-new-branding-for-jeuveau/2473470/Evolus, Inc. is unveiling its new branding for Jeuveau (prabotulinumtoxinA-xvfs). The new Jeuveau imagery reflects today’s consumers, many of whom are millennials and younger. The “Jeuveau, You See Me” marketing campaign uses inclusive messaging to encourage
- New Scope of Practice Guidelines and Other Legal Changes: Are You Up to Speed?https://modernaesthetics.com/news/new-scope-of-practice-guidelines-and-other-legal-changes-are-you-in-compliance/2473465/Summer vacation is good for relaxing and taking a bit of a break from the daily grind, but it is also a great time to get up to speed on changing regulations that may impact the services your practice provides and who performs those services. For example, recently, in New York State (&l
- Summer Slump? Use Your Free Time to Get Aheadhttps://modernaesthetics.com/news/summer-slump-use-your-free-time-to-get-ahead/2473463/Summer is notoriously slow for many aesthetic practices. instead of becoming distraught over the lower volume, use the slower times to get ahead of the fall and winter rush, says Jay A. Shorr BA, MBM-C, CAC I-XVI, founder and managing partner of Shorr Solutions in Coral Springs, Fla.
- EWG Survey: Men’s Use of Personal Care Products Doubles Since 2004https://modernaesthetics.com/news/ewg-survey-mens-use-of-personal-care-products-doubles-since-2004/2473459/Men’s use of personal care products has doubled since 2004, according to new consumer survey commissioned by the Environmental Working Group. Specifically, the average adult man in the U.S. uses 11 different personal care products each day – nearly twice as ma
- Two in Three Cosmetic Surgery Injections in the UK Not Administered by Doctorshttps://modernaesthetics.com/news/two-in-three-cosmetic-surgery-injections-in-the-uk-nor-administered-by-doctors/2473453/Two in three neuromodulators or fillers in the UK are not administered by doctors, new research shows. For the study, researchers from UCL in London evaluated 3,000 websites to identify 1,224 independent clinics and 3,667 practitioners who performed cosmetic injections. Of the
- SK-II Introduces Pitera Expert Panelhttps://modernaesthetics.com/news/sk-ii-introduces-pitera-expert-panel/2473450/SK-II’s PITERA may reduce the Aging Trigger Factor (AT-0), potentially slowing skin aging, according to research presented at the World Congress of Dermatology 2023 in Singapore. AT-0 accelerates signs of aging via a chain reaction, even as early as i
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,